Anti-Cardiolipin Antibodies (ACA)
An autoantibody marker used in anti-phospholipid syndrome.
| Tube | Serum Gel |
|---|---|
| ID | 12750 |
| Availability | Weekdays |
| Additional Information | Anti-cardiolipin antibodies have been associated with thrombosis (arterial and venous) in SLE (secondary anti-phospholipid syndrome) and also occur in isolation in patients with thrombosis and no evidence of lupus (primary anti-phospholipid syndrome). IgG Anti-cardiolipin antibodies have been associated with thrombosis (arterial and venous) in SLE (secondary anti-phospholipid syndrome) and also occur in isolation in patients with thrombosis and no evidence of lupus (primary anti-phospholipid syndrome). IgG- anti-Beta- 2-glycoprotein 1 Antibodies will also be tested when anti-cardiolipin Ab are requested. Also see entry for anti-beta-2-glycoprotein 1 Ab. Moderate rises in cardiolipin antibodies may occur transiently after infection. It is recommended that positive results are confirmed after 12 weeks. Antibody concentrations do not correlate with extent or severity of thrombosis. |
| Turn Around | 7 days |
| Send to | Leeds General Infirmary Clinical Immunology Old Medical School Great George Street Leeds LS1 3EX |
| Collection Con | No restrictions |
| Frequency | Daily |
| Sample REQ | Blood |
| Ref. Range (Male) | <20 |
| Ref. Range (Female) | <20 |
| Ref. Range (Paed) | <20 |
| Units | GPL-U/mL |
| IP Acute TAT | - Contact Laboratory |
| IP Routine TAT | 7 days |
| GP Acute TAT | - Contact Laboratory |
| GP Routine TAT | 7 days |
| Telepath | APS1L |
| ICE Codes | IACA |
